2409, 2012

UK’s Globe and Mail Blows the Lid Off of Transvaginal Mesh Disaster in Britain

September 24th, 2012|Commercial Litigation, Medical Malpractice, Personal Injury, Product Liability|Comments Off on UK’s Globe and Mail Blows the Lid Off of Transvaginal Mesh Disaster in Britain

As this blog and other media sources have reported, the complications associated with transvaginal mesh products can range from excruciating to fatal. In 2011, the U.S. Food and Drug Administration finally stepped up and released this statement: ìserious complications associated with surgical mesh for transvaginal […]

1409, 2012

Pradaxa Getting Hammered With Lawsuits: Johnson & Johnson Sees Opening with Xarelto

September 14th, 2012|Commercial Litigation, Drug Safety, Personal Injury, Product Liability|Comments Off on Pradaxa Getting Hammered With Lawsuits: Johnson & Johnson Sees Opening with Xarelto

As this blog and other media sources have reported recently, the rash of lawsuits against Pradaxa may finally be having an affect, not only on the drug’s manufacturer, the German company Boehringer Ingelheim, but also on the entire market for blood thinning drugs.
Last Friday, Johnson […]

509, 2012

Could Wave of Pradaxa Lawsuits Spark a Sea Change in How Drug Manufacturers and the FDA Operate?

September 5th, 2012|Commercial Litigation, Drug Safety|Comments Off on Could Wave of Pradaxa Lawsuits Spark a Sea Change in How Drug Manufacturers and the FDA Operate?

Pradaxa, the blood-thinning drug made by Boehringer Ingelheim, once had so much promise.
After years of dealing with the unpleasant side effects of Coumadin (a.k.a. Warfarin) – which included brain hemorrhages and bleeding problems – doctors and patients alike were desperate for an alternative blood-thinner that […]